BDa | HF/HSb | Controlc | ANOVA | Post-hoc | |||||
---|---|---|---|---|---|---|---|---|---|
Mean | SD_SE | Mean | SD_SE | Mean | SD_SE | p | |||
Body Composition | GLOBAL MASS (g) | 495.5 | 33.3 | 729.7 | 67.0 | 627.1 | 62.8 | 0.000 | a < c < b |
GLOBAL FAT (g) | 93.9 | 25.4 | 248.1 | 59.5 | 159.0 | 39.2 | 0.000 | a < c < b | |
GLOBAL LEAN (g) | 386.8 | 31.3 | 461.9 | 31.8 | 450.0 | 56.16 | 0.000 | a < c.b | |
GLOBAL BMC (g) | 14.75 | 0.99 | 19.71 | 1.61 | 17.96 | 1.90 | 0.000 | a < c < b | |
Obesity Parameters | GLOBAL PFAT (%) | 18.9 | 4.5 | 33.7 | 5.4 | 25.3 | 5.5 | 0.000 | a < c < b |
AC (cm) | 21.2 | 0.7 | 26.5 | 1.4 | 23.4 | 1.3 | 0.000 | a < c < b | |
CFM (g) | 22.0 | 7.6 | 64.1 | 15.3 | 34.6 | 9.3 | 0.000 | a < c < b | |
Perirenal AT (g) | 10.6 | 3.4 | 34.5 | 7.5 | 12.6 | 3.4 | 0.000 | a.c < b | |
Peri-epididymal AT (g) | 9.2 | 2.7 | 25.5 | 5.6 | 16.3 | 3.5 | 0.000 | a < c < b | |
ex vivo Fat Mass (g) | 19.8 | 5.8 | 60.0 | 12.1 | 28.9 | 6.4 | 0.000 | a < c < b | |
Lipid Profile | TRIGLY (g/l) | 0.97 | 0.09 | 0.64 | 0.03 | 1.12 | 0.09 | 0.000 | b < a.c |
Total CHOL (g/l) | 0.94 | 0.09 | 0.64 | 0.03 | 1.10 | 0.05 | 0.075 | ||
HDL CHOL (g/l) | 0.48 | 0.04 | 0.49 | 0.04 | 0.62 | 0.03 | 0.013 | a.b < c | |
LDL CHOL (g/l) | 0.27 | 0.07 | 0.28 | 0.03 | 0.26 | 0.03 | 0.258 | ||
NEFA (mmol/l) | 0.49 | 0.03 | 0.28 | 0.01 | 0.75 | 0.08 | 0.000 | b < a < c | |
Hormonal Profile | INSULIN (ng/ml) | 0.475 | 0.039 | 0.633 | 0.080 | 0.765 | 0.052 | 0.001 | a < c |
LEPTIN (ng/ml) | 4.300 | 0.448 | 19.144 | 0.915 | 10.692 | 1.246 | 0.000 | a < c < b | |
ADIPONECTIN (μgm/l) | 11.292 | 0.590 | 12.563 | 0.762 | 12.240 | 0.689 | 0.443 |